| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Jazz Pharmaceuticals Plc (JAZZ) has 19 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. JAZZ is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.18M | $268.95M | - | |
| Dir | 390.7K | $88.82M | - | |
| CEO | 152.2K | $34.60M | - | |
| VP | 72.6K | $16.51M | - | |
| CFO | 59.6K | $13.55M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2017 | Winningham Rick E64 | Director | Sell | 5,000 | $150.00 | $750,000.00 | -32.5% | |
| May 15, 2017 | Miller Michael Patrick46 | EVP, Us Commercial | Sell | 200 | $152.98 | $30,596.00 | -0.9% | |
| May 11, 2017 | Cozadd Bruce C59 | Chairman &CEO | Sell | 30,000 | $153.47 | $4,604,145.89 | -5.0% | |
| May 9, 2017 | Hooper Suzanne Sawochka | EVP &General Counsel | Sell | 2,500 | $160.00 | $400,000.00 | -6.3% | |
| Apr 27, 2017 | Hooper Suzanne Sawochka | EVP &General Counsel | Sell | 2,500 | $160.00 | $400,000.00 | -5.9% | |
| Apr 27, 2017 | Wilson Karen J | SVP, Finance &Pao | Sell | 1,275 | $160.00 | $204,000.00 | -5.7% | |
| Apr 17, 2017 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $152.56 | $30,512.00 | -0.9% | |
| Apr 11, 2017 | Cozadd Bruce C59 | Chairman &CEO | Sell | 1,000 | $152.12 | $152,120.00 | -0.3% | |
| Apr 10, 2017 | Wilson Karen J | SVP, Finance &Pao | Sale+OE | 11,458 | $152.24 | $1,744,365.92 | -20.4% | |
| Mar 15, 2017 | Miller Michael Patrick46 | SVP, Us Commercial | Sell | 200 | $137.89 | $27,578.00 | -0.9% |